MedTrace Logo

MEDIHONEY® Gel Versus Collagenase for Wound Debridement

NCT02482948 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-12-02

No results posted yet for this study

Summary

The purpose of this study is to compare how well two products, Active Leptospermum Honey (ALH) (MEDIHONEY® Gel) and Collagenase (Santyl®), in removing the nonviable (non living) tissue.

Conditions

  • Ulcer
  • Wounds

Interventions

DEVICE

Active Leptospermum Honey (Medihoney)

STudy agent to be applied to the wound daily.

DRUG

Collagenase

Study agent to be applied daily to the wound.

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Ravi Patel, MD · Innovative Healing Systems

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02482948 on ClinicalTrials.gov